drugset / Trial / NCT00213291
Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a study to determine the safety and effectiveness of Darbepoetin (Aranesp) given every 14 to 28 days to treat low red blood cells in children with chronic kidney failure.
Timeline
- Start
- 2005-04
- Primary completion
- 2005-09
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 0.9 ug/kg | Subcutaneous |
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 20 ug | Subcutaneous |